In disputes, the party with a better understanding of the facts has a structural advantage.

  • LITH logo
    Solvex logo
    Verdant logo

3 days →45 min

3 days →45 min

Pleadings matrix

Pleadings matrix

2 weeks → hours

2 weeks → hours

First-draft chronology

First-draft chronology

4 weeks → 1 day

4 weeks → 1 day

Evidence matrix

Evidence matrix

weeks → hours

weeks → hours

Document coding

Document coding

The Reality

The best case doesn't always win.
The best-resourced one usually does.

The best case doesn't always win.
The best-resourced one usually does.

In both high-volume and complex litigation, outcomes are too often determined by which party can dedicate more resources to understanding the facts. The team with deeper capacity to map allegations, trace contradictions, and construct comprehensive chronologies holds a decisive structural advantage - regardless of merit.

Cicero was built to eliminate that asymmetry.

THE CICERO APPROACH

You specialise.
Your technology should too.

The probative value of evidence is determined by being able to distinguish facts from allegations from assertions from opinions. Litigators require tools that understand the nuances of their trade.

01

Pleading Analysis

Cicero extracts every allegation from the Statement of Claim and maps each to the corresponding response in the Defence. A complete pleadings matrix, delivered in minutes rather than weeks.

02

Chronologies & Timelines

Generate comprehensive chronologies from thousands of source documents. Filter for relevance against specific allegations or issues, then export as hearing-ready schedules of evidence.

03

Investigations

Cross-document search across hundreds of thousands of files in a single query. Surface the evidence that supports your theory of the case -- or identify the gaps before opposing counsel does.

04

Extractions & Coding

Define the data points that matter and Cicero codes them across every relevant document -- contracts, witness statements, correspondence. Structured data extraction at a scale that manual review cannot match.


05

Evidence Matrices

Evaluate propositions against the full document set. Every gap is identified, every contradiction is visible. A clear, auditable view of where the case is strong and where it requires further work.

06

Dramatis Personae

Every individual identified across the document set, mapped by role, relationship, and relevance. Track who said what, when they said it, and where their account diverges from another's.

#

Allegations

Purdue Pharma

Sackler Family

McKinsey & Company

Comments

1

Purdue marketed OxyContin as less addictive than competing opioids without scientific basis

Denied

Denied

Does Not Know

2

Defendants knew OxyContin was being diverted and misused and continued marketing regardless

Denied in Part

Denied

Does Not Know

3

Purdue paid physicians through speaking fees to act as de facto sales representatives

Admitted with
Qualification

Denied

Does Not Know

4

McKinsey advised Purdue to "turbocharge" OxyContin sales following the 2007 federal guilty plea

Admitted

Does Not Know

Denied in Part

5

Members of the Sackler family directed Purdue's aggressive marketing strategy

Admitted with
Qualification

Denied

Does Not Know

#

Allegations

Purdue Pharma

Sackler Family

McKinsey & Company

Comments

1

Purdue marketed OxyContin as less addictive than competing opioids without scientific basis

Denied

Denied

Does Not Know

2

Defendants knew OxyContin was being diverted and misused and continued marketing regardless

Denied in Part

Denied

Does Not Know

3

Purdue paid physicians through speaking fees to act as de facto sales representatives

Admitted with
Qualification

Denied

Does Not Know

4

McKinsey advised Purdue to "turbocharge" OxyContin sales following the 2007 federal guilty plea

Admitted

Does Not Know

Denied in Part

5

Members of the Sackler family directed Purdue's aggressive marketing strategy

Admitted with
Qualification

Denied

Does Not Know

01

Pleading Analysis

Cicero extracts every allegation from the Statement of Claim and maps each to the corresponding response in the Defence. A complete pleadings matrix, delivered in minutes rather than weeks.

Data Point

Dr. Russell Portenoy

Dr. Lynn Webster

Dr. Scott Fishman

Dr. Perry Fine

Dr. Joel Saper

Comments

Speciality

Pain Medicine

Pain Medicine

Pain Medicine

Pain Medicine

Headache Medicine

Contract Date

03-12-1999

07-22-2001

11-04-2000

02-17-2002

09-08-2001

Annual Fee

$158,000

$214,000

$187,500

$96,000

$112,000

Talks Delivered

98

142

113

67

74

Key Claim Made

Long-term opioid therapy safe for non-cancer pain

Pseudoaddiction misdiagnosed as true addiction

Addiction risk overstated in medical literature

OxyContin appropriate for moderate chronic pain

Opioid therapy improves patient quality of life

Disclosed to Patients

🚩 No

🚩 No

🚩 No

🚩 No

🚩 No

FDA Complaint Filed

Yes

Yes

No

No

Yes

04

Extractions & Coding

Define the data points that matter and Cicero codes them across every relevant document -- contracts, witness statements, correspondence. Structured data extraction at a scale that manual review cannot match.

02

Chronologies & Timelines

Comprehensive first-draft chronologies generated from thousands of source documents. Structured, editable, and exportable as tribunal-ready Days of Evidence tables.

What did Purdue know about OxyContin diversion prior to 2007?

DOC-0847

Purdue regional managers instructed to maintain relationships and continue targeting

Internal sales report flagging 11 high-prescribing physicians suspected of facilitating diversion

98%

Q3_Sales_Region_Report_Appalachia_2004.pdf

DOC-1203

Legal counsel advises against voluntary disclosure to federal investigators

Email chain between Purdue executives discussing DEA inquiry into OxyContin abuse patterns

94%

OxyContin_Misuse_Tracking_Study_Final_2003.pdf

DOC-0847

Study results withheld from FDA during label review negotiations

Market research study commissioned by Purdue tracking OxyContin misuse rates by geography

87%

Sales_Incentive_Structure_Q1_2006_Internal.docx

03

Investigations

Cross-document search across hundreds of thousands of files in a single query. Surface the evidence that supports your theory of the case -- or identify the gaps before opposing counsel does.

#

Allegation

Supporting Evidence

Contradictory Evidence

Comments

1

Purdue misrepresented OxyContin's addiction risk to physicians and patients

Appalachia Regional Sales Report Q3 2004

2 propositions

Plaintiff Bundle

OxyContin Prescribing Guidelines 1996

1 proposition

Defence Bundle

Denied

Denied

Does Not Know

2

Purdue executives were aware of widespread diversion and concealed it from federal regulators

DEA Inquiry Response Strategy Email Chain May 2005

3 propositions

Subpoenaed Documents

Purdue DEA Cooperation Statement 2005

2 propositions

Defence Bundle

3

McKinsey advised Purdue to increase marketing intensity following the 2007 guilty ple

McKinsey Sales Strategy Presentation 2009

3 propositions

Subpoenaed Documents

McKinsey Engagement Scope Letter 2009

2 propositions

Defence Bundle

4

Sackler family members directed Purdue's marketing strategy while misrepresenting their operational involvement

Purdue Board Minutes April 2014

2 propositions

Subpoenaed Documents

Sackler Family Statement of Non-Involvement 2018

2 propositions

Defence Bundle

2 propositions

3

McKinsey advised Purdue to increase marketing intensity following the 2007 guilty plea

Admitted with
Qualification

Denied

Does Not Know

4

McKinsey advised Purdue to "turbocharge" OxyContin sales following the 2007 federal guilty plea

Admitted

Does Not Know

Denied in Part

5

Members of the Sackler family directed Purdue's aggressive marketing strategy

Admitted with
Qualification

Denied

Does Not Know

05

Evidence Matrices

Evaluate propositions against the full document set. Every gap is identified, every contradiction is visible. A clear, auditable view of where the case is strong and where it requires further work.

Richard Sackler

Chairman & President

Selected

Howard Udell

Chief Legal Officer

Martin Fried

Vice President of Sales

Selected

Kathe Sackler

Board Member

Selected

Contradictory Evidence

RS

OxyContin has an extremely low potential for abuse and addiction in patients treated for legitimate pain conditions

Purdue Public Statement March 1998

Agreed Bundle

para 4

Focus sales efforts on pain clinics in economically distressed regions — these patients have fewer alternatives and higher compliance

Regional Sales Strategy Memo March 2003

Subpoenaed Documents

para 19

RS

We should not stop selling to the most productive doctors even where there is reason to believe they are running pill mills

Internal Board Memorandum October 2008

Subpoenaed Documents

para 14

OxyContin has an extremely low potential for abuse and addiction in patients treated for legitimate pain conditions

Purdue Public Statement March 1998

Agreed Bundle

para 7

RS

The notion that Purdue targeted vulnerable patient populations is categorically false

Purdue Press Statement January 2004

Agreed Bundle

para 4

Focus sales efforts on pain clinics in economically distressed regions — these patients have fewer alternatives and higher compliance

Regional Sales Strategy Memo March 2003

Subpoenaed Documents

para 19

06

Dramatis Personae

Every individual identified across the document set, mapped by role, relationship, and relevance. Track who said what, when they said it, and where their account diverges from another's.

"Maddocks piloted Cicero during a complex international dispute. With the time and resources that we had available, we would not have been able to complete this task on time without Cicero. The Cicero team was able to grasp the finer nuances of our case quickly, work with us to adapt the solution, and deliver functionality on demand. What impressed us most was their ability to understand complex evidentiary matters and respond with client-ready solutions in real time. This positive experience means we are now adopting Cicero as a firmwide solution."

Shaun Temby

Partner-in-Charge, Litigation and Disputes

"Maddocks piloted Cicero during a complex international dispute. With the time and resources that we had available, we would not have been able to complete this task on time without Cicero. The Cicero team was able to grasp the finer nuances of our case quickly, work with us to adapt the solution, and deliver functionality on demand. What impressed us most was their ability to understand complex evidentiary matters and respond with client-ready solutions in real time. This positive experience means we are now adopting Cicero as a firmwide solution."

Shaun Temby

Partner-in-Charge, Litigation and Disputes

How it works

AI performs the analysis.
Your lawyers make the decisions.

Cicero does not replace legal judgment. It eliminates the mechanical work that delays it. A hybrid workflow where AI handles first-pass analysis at scale, and your team retains full control to verify, refine, and act on structured outputs. Every output is traceable, editable, and designed to integrate directly into existing litigation workflows.

AUTOMATED

AUTOMATED

AI First Pass

AI First Pass

Cicero ingests the full document set and runs structured analysis — pleadings mapping, chronology extraction, investigation queries, and data coding — in minutes.

HUMAN-IN-THE-LOOP

Lawyer Review & Refinement

Lawyer Review & Refinement

Your team reviews AI-generated outputs with full source traceability. Edit chronology entries, reclassify extractions, verify evidence links — every output is a starting point, not a final answer.

SEAMLESS SYNC

Export & Integrate

Export & Integrate

Push refined outputs back into iManage or Relativity. Export matrices, chronologies, and coding decisions to Word, Excel, or directly into your review platform.

Integrations

Work where your documents live.

Pull documents directly from your DMS or review platform. Run analysis, then push refined outputs back - keeping your existing workflows intact.

*importS from Relativity, iMANAGE and FROM your local COMPUTER. NetDocuments, Nuix, and SharePoint — are on the way

Data Privacy

Your client data deserves the highest standard of protection.

Cicero is powered exclusively by privately hosted language models. No shared infrastructure. No data leaves your sovereign jurisdiction.

ISO 27001

Certified information security management across all systems and processes.

SOC Type II

Independent verification of security controls, availability, and confidentiality over time.

ISO 42001

One of the first AI companies globally to achieve the international standard for AI management systems.

GDPR Compliant

Full compliance with European data protection regulation. Deploy in any jurisdiction using secure private cloud.

Book a Working Session.

See how Cicero analyses a real matter end to end.

We work with your documents or a representative dataset to demonstrate the platform in practice.

Book a Working Session.

See how Cicero analyses a real matter end to end.

We work with your documents or a representative dataset to demonstrate the platform in practice.

Book a Working Session.

See how Cicero analyses a real matter end to end.

We work with your documents or a representative dataset to demonstrate the platform in practice.